1111 Lincoln Road, Fourth Floor, Miami Beach, FL 33140| Phone: 786-497 1865


  • Meticulous Capital is a biopharmaceutical investment management firm founded in 2009, reserved for institutional and sophisticated individual investors.  The firm’s specialized investment universe is domestic and foreign publicly-listed biotechnology and pharmaceutical corporations.  The medicines these companies work to deliver to patients target the full range of therapeutic indications, including oncology, cardiovascular disease, metabolic syndrome, inflammation, and other areas of large unmet need. 
  • Meticulous Capital’s investment objective is to achieve for its clients the maximum absolute return on capital consistent with principles designed to minimize risk of permanent capital loss.  This is accomplished through the purchase and sale of publicly traded domestic and foreign biopharmaceutical securities, such as common stock, options and stock index futures.
  • Meticulous Capital employs professionals with a distinguished background in medical sciences, investment research and financial valuation analysis, along with a strong investment management track record.